Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Clinical Marker for Perilymph Fistula
Telian, Steven A.
University of Michigan Ann Arbor, Ann Arbor, MI, United States
Search 12 grants from Steven Telian
Search grants from University of Michigan Ann Arbor
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
Glucose Modifications of Proteins in Diabetic Nephropathy
1/2-Personalized Antidepressant Adherence Strategies for Depressed Elders
Regulation of T Cell Activity During Chronic Infections
Post-Earthquake Fire Risk: Methodology and Systems Aspects of Mitigation
Recently added grants:
Impact of concomitant chemotherapy on HIV resistance to cART and reservoir size
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer
Memory-like NK cells for enhanced immunotherapy of post transplant relapse in patients with myeloid malignancies
Electronic Pediatric Office Systems to Support Treatment for Parental Tobacco Use
Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
5R01DC001285-03
Application #
3218000
Study Section
Special Emphasis Panel (SRC (01))
Project Start
1991-07-15
Project End
1996-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Related projects
NIH 1995
R01 DC
Development of Clinical Marker for Perilymph Fistula
Telian, Steven A. / University of Michigan Ann Arbor
NIH 1994
R01 DC
Development of Clinical Marker for Perilymph Fistula
Telian, Steven A. / University of Michigan Ann Arbor
NIH 1993
R01 DC
Development of Clinical Marker for Perilymph Fistula
Telian, Steven A. / University of Michigan Ann Arbor
Publications
Sun, Q; Disher, M J; Rustad, T et al.
(1998)
AP30, a differential protein marker for perilymph and cerebrospinal fluid in middle ear fluid, has been purified and identified as human apolipoprotein D.
Biochim Biophys Acta 1384:405-13
Comments
Be the first to comment on Steven Telian's grant